AZDDQ yields 2000000.00% · JNJ yields 2.13%● Live data
📍 AZDDQ pulled ahead of the other in Year 1
Combined, AZDDQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AZDDQ + JNJ for your $10,000?
Azure Dynamics Corporation engages in the development and supply of electric and hybrid electric power trains and vehicle control systems for light and heavy duty commercial vehicles in North America. The company's hybrid electric vehicle systems include an electric motor, energy storage system, and additional power source, such as internal combustion engine/generator; and electric vehicle systems comprising electric motor and an energy storage system. The company offers series and parallel hybrid power train products comprising stripped hybrid chassis for general delivery vans, and a cutaway hybrid chassis for shuttle buses and other vocational trucks; and low emission electric power freeze and lift systems for refrigeration, utility, and telecom truck applications. It also integrates Force Drive electric powertrain auxiliaries and battery packs, as well as sells the battery electric transit connects. In addition, the company provides electric drive systems, as well as electric drive components comprising AC motors, inverters, converters, controllers, battery chargers, and gear boxes. It has operations in Canada, the United States, the United Kingdom, and other countries. The company was incorporated in 1993 and is headquartered in Oak Park, Michigan. Azure Dynamics Corp. is in reorganization.
Full AZDDQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.